Beta blockers Flashcards
What differentiates 3rd gen B blockers?
They have vasodilatory properties: alpha block or NO release.
They can be either non-selective or B1-selective.
Example of lipophilic BB?
propanolol, penbutolol
Example of hydrophilic BB?
atenolol, nadolol
Which BB has an uncharacteristic short duration and fast onset?
esmolol
Which enzyme’s genotype is a major determinant in interindividual differences of metabolism?
CYP2D6
General effects of SHORT-TERM use of BBs on CVS:
Decreased CO (B1 block) Increased PVR (B2 block = A1 vasoconstriction is unopposed)
BBs Anti-HTN properties can be explained by:
1) Sustained use results in decreased TPR in HTN patients
2) B1 block –> decreased renin secretion from JG cells (PINDOLOL does not affect)
3) Vasodilatory properties of some BBs
This effect or property of some BBs involves the inhibition or total abolition of action potential from being propagated across the membrane via SODIUM CHANNEL BLOCK.
What is the physiological basis behind treatment with these drugs?
Which drugs exhibit this pharmacological effect?
Membrane Stabilizing Activity. Decreased sinus rhythm, conduction –> generalized suppression of myocardial function.
PALOCA: Propranolol Alprenolol Labetalol Oxprenolol Carvedilol Acebutolol
Advantages of sodium channel blockade include:
prophylaxis to prevent recurrent MI and sudden death
limits size of infarct
reduce mortality
Disadvantages of sodium channel blockade
latent heart failure to overt heart failure
Cardioselective BB blockers block which receptor?
B1
Cardioselective BBs include the following drugs:
CABNAME: Celiprolol Acebutolol Betaxolol Nebivolol Atenolol Metoproplol Esmolol
Cardioselective BBs are preferred in patients with:
Bronchospasm/asthma/COPD
DM
Raynaud’s
(because B2 is not blocked…B2 blockage results in vasoconstriction and bronchoconstriction)
Beta blockers with partial agonist properties are said to exhibit:
Intrinsic sympathomimetic activity (ISA).
The structural specificity of the drugs allowing competitive binding to the receptor (antagonist activity) and partial interaction at the receptor’s activation site (agonist activity).
BBs with partial agonistic activity include:
APOCAP Alprenolol Pindolol Oxprenolol Carteolol Acebutolol Penbutolol